Press Releases
Imago BioSciences to Participate in the 2022 Wedbush PacGrow Healthcare Conference
Aug 03, 2022
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at EHA 2022
Jun 10, 2022
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at EHA 2022
Jun 10, 2022
Imago BioSciences to Host Virtual Investor Event
Jun 06, 2022
Imago BioSciences to Participate in Upcoming Investor Conferences
May 16, 2022
Displaying 11 - 15 of 71